Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Cyclooxygenase (COX) catalyses the first committed step in the synthesis of prostanoids, a large family of arachidonic acid metabolites comprising prostaglandins, prostacyclin, and thromboxanes, and is a major target of non-steroidal anti-inflammatory drugs (NSAIDs). COX exists as constitutive and inducible isoforms. COX-2 is the inducible isoform, rapidly expressed in several cell types in response to growth factors, cytokines, and pro-inflammatory molecules. Since its discovery in the early 1990s, COX-2 has emerged as a major player in inflammatory reactions in peripheral tissues. By extension, COX-2 expression in brain has been associated with pro-inflammatory activities, thought to be instrumental in neurodegenerative processes of several acute and chronic diseases. However, 2 major aspects should be borne in mind. First, in the central nervous system, COX-2 is expressed under normal conditions and contributes to fundamental brain functions, such as synaptic activity, memory consolidation, and functional hyperemia. Second, "neuroinflammation" is a much more controlled reaction than inflammation in peripheral tissues, and in many cases is triggered and sustained by activation of resident cells, particularly microglia. In spite of the intense research of the last decade, the evidence of a direct role of COX-2 in neurodegenerative events is still controversial. This article will review new data in this area, focusing on some major human neurological diseases, such as multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease, Creutzfeldt-Jakob disease, and Alzheimer disease. Furthermore, the emerging role of COX-2 in behavioral and cognitive functions will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,978
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Yamagata, K., Andreasson, K. I., Kaufmann, W. E., Barnes, C. A., & Worley, P. F. (1993) · Neuron · doi:10.1016/0896-6273(93)90192-t · Cited by 1,226
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
Prostaglandins stimulate calcium-dependent glutamate release in astrocytes
Bezzi, P., Carmignoto, G., Pasti, L., Vesce, S., Rossi, D., Rizzini, B. L., Pozzan, T., & Volterra, A. (1998) · Nature · doi:10.1038/34651 · Cited by 1,143
Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., Jaffee, B. D., Covington, M. B., Contel, N. R., Eng, V. M., Collins, R. J., Czerniak, P. M., et al. (1995) · Nature · doi:10.1038/378406a0 · Cited by 969
Khoury, S. J., Hancock, W. W., & Weiner, H. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1355 · Cited by 708
Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
O'Neill, G. P., & Ford-Hutchinson, A. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80263-t · Cited by 707
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Kaufmann, W. E., Worley, P. F., Pegg, J., Bremer, M., & Isakson, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2317 · Cited by 593
Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide
Minghetti, L. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00052-x · Cited by 567
Self-citationCharacterization of inducible cyclooxygenase in rat brain
Breder, C. D., Dewitt, D., & Kraig, R. P. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903550208 · Cited by 533
Cyclooxygenase-2—10 Years Later
Hinz, B., & Brune, K. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.367 · Cited by 518
Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503 · cited 1×
“Moderate COX-1 immunoreactivity was observed in some neuronal somata and processes and in few glial cells in both groups, suggesting that the greater potential for PG synthesis is associated to COX-2 and microglial cells ( 53 ).”
BackgroundCyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
Pasinetti, G. M., & Aisen, P. S. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00218-8 · Cited by 457
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428 · cited 3×
“By contrast, the immunoregulatory cytokine transforming growth factor-b and PGE2 were increased (54, 55).”
BackgroundCyclooxygenase-2: Molecular Biology, Pharmacology, and Neurobiology
O'Banion, M. K. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i1.30 · Cited by 404
Peroxynitrite Inhibits Glutamate Transporter Subtypes
Trotti, D., Rossi, D., Gjesdal, O., Levy, L. M., Racagni, G., Danbolt, N. C., & Volterra, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.5976 · Cited by 372
The link between excitotoxic oligodendroglial death and demyelinating diseases
Matute, C., Alberdi, E., Domercq, M., Pérez-Cerdá, F., Pérez-Samartı́n, A., & Sánchez-Gómez, M. V. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01746-x · Cited by 348
Mirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
Novel anti-inflammatory therapy for Parkinson's disease
Gao, H.-M., Liu, B., Zhang, W., & Hong, J.-S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00176-7 · Cited by 324
Drachman, D. B., Frank, K., Dykes‐Hoberg, M., Teismann, P., Almer, G., Przedborski, S., & Rothstein, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10374 · Cited by 307
Cyclooxygenase-2 Regulates Prostaglandin E2Signaling in Hippocampal Long-Term Synaptic Plasticity
Chen, C., Magee, J. C., & Bazan, N. G. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.87.6.2851 · Cited by 294
Cyclooxygenases and the Central Nervous System
Kaufmann, W. E., Andreasson, K. I., Isakson, P. C., & Worley, P. F. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00128-7 · Cited by 285
Elevated CSF prostaglandin E 2 levels in patients with probable AD
Montine, T. J., Sidell, K. R., Crews, B. C., Markesbery, W. R., Marnett, L. J., Roberts, L. J., & Morrow, J. D. (1999) · Neurology · doi:10.1212/wnl.53.7.1495 · Cited by 277
Cyclooxygenase-2 Contributes to Functional Hyperemia in Whisker-Barrel Cortex
Niwa, K., Araki, E., Morham, S. G., Ross, M. E., & Iadecola, C. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00763.2000 · Cited by 261
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01389-x · Cited by 251
Bazan, N. G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300013-jlr200 · Cited by 247 · cited 1×
“PGE2, which is preferentially formed during the enzymatic activity of COX-2 rather than of COX-1, could participate to synaptic plasticity through several mechanisms, including modulation of adrenergic, noradrenergic, and glutamatergic neurotransmission, remodeling of actin in the cytoskeleton thus influencing the sha…”
BackgroundConstraints on prostaglandin biosynthesis in tissues.
Marshall, P. J., Kulmacz, R. J., & Lands, W. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61380-8 · Cited by 222
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
Aisen, P. S. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00133-3 · Cited by 203
Yermakova, A. V., Rollins, J., Callahan, L. M., Rogers, J., & OʼBanion, M. K. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199911000-00003 · Cited by 188
Neuronal Apoptosis in Creutzfeldt-Jakob Disease
Gray, F., Chrétien, F., Adle-Biassette, H., Dorandeu, A., Ereau, T., Delisle, M.-B., Kopp, N., Ironside, J. W., & Vital, C. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199904000-00002 · Cited by 171
Neuroinflammation, COX-2, and ALS—a dual role?
Consilvio, C., Vincent, A. M., & Feldman, E. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.12.009 · Cited by 171
15-Deoxy-Δ 12,14 -prostaglandin J 2 : The endogenous electrophile that induces neuronal apoptosis
Kondo, M., Shibata, T., Kumagai, T., Osawa, T., Shibata, N., Kobayashi, M., Sasaki, S., Iwata, M., Noguchi, N., & Uchida, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112212599 · Cited by 165
Nagy, Z., Esiri, M. M., & Smith, A. D. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00293-0 · Cited by 155
Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy
Yasojima, K., Tourtellotte, W. W., McGeer, E. G., & McGeer, P. L. (2001) · Neurology · doi:10.1212/wnl.57.6.952 · Cited by 148
Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients
Almer, G., Teismann, P., Stevic, Z., Halaschek–Wiener, J., Deecke, L., Kostic, V., & Przedborski, S. (2002) · Neurology · doi:10.1212/wnl.58.8.1277 · Cited by 147
Post-Training Cyclooxygenase-2 (COX-2) Inhibition Impairs Memory Consolidation
Teather, L. A., Packard, M. G., & Bazan, N. G. (2002) · Learning & Memory · doi:10.1101/lm.43602 · Cited by 147
Inflammation in multiple sclerosis: the good, the bad, and the complex
Martino, G., Adorini, L., Rieckmann, P., Hillert, J., Kallmann, B., Comi, G., & Filippi, M. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00223-5 · Cited by 142
Lukiw, W. J., & Bazan, N. G. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971215)50:6<937::aid-jnr4>3.0.co;2-e · Cited by 141
Hoozemans, J. J. M., Brückner, M. K., Rozemuller, A. J. M., Veerhuis, R., Eikelenboom, P., & Arendt, T. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.8.678 · Cited by 118
Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease
Yermakova, A., & O'Banion, M. K. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00303-7 · Cited by 116
Drachman, D. B., & Rothstein, J. D. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<792::aid-ana14>3.0.co;2-5 · Cited by 114
Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion
Rose, J. W., Hill, K. E., Watt, H. E., & Carlson, N. G. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.12.021 · Cited by 107
Sairam, K., Saravanan, K. S., Banerjee, R., & Mohanakumar, K. P. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04174-4 · Cited by 106
Minghetti, L., Greco, A., Cardone, F., Puopolo, M., Ladogana, A., Almonti, S., Cunningham, C., Perry, V. H., Pocchiari, M., & Levi, G. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.866 · Cited by 101
Self-citationRicceri, L., Minghetti, L., Moles, A., Popoli, P., Confaloni, A., Simone, R. D., Piscopo, P., Scattoni, M. L., Luca, M. D., & Calamandrei, G. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.025 · Cited by 98
Self-citationCerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis
Greco, A., Minghetti, L., Sette, G., Fieschi, C., & Levi, G. (1999) · Neurology · doi:10.1212/wnl.53.8.1876 · Cited by 98
Self-citationIntrahippocampal infusion of a cyclooxygenase-2 inhibitor attenuates memory acquisition in rats
Rall, J., Mach, S. A., & Dash, P. K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02248-0 · Cited by 95
Shaw, K. N., Commins, S., & O'Mara, S. M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02643.x · Cited by 95
Aloisi, F., Serafini, B., & Adorini, L. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00231-9 · Cited by 93
Simone, R. D., Ajmone‐Cat, M. A., & Minghetti, L. (2004) · Molecular Neurobiology · doi:10.1385/mn:29:2:197 · Cited by 93
Self-citationCOX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells
Shaftel, S. S., Olschowka, J. A., Hurley, S. D., Moore, A. H., & O’Banion, M. K. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.006 · Cited by 89
Maihöfner, C., Probst‐Cousin, S., Bergmann, M., Neuhuber, W., Neundörfer, B., & Heuß, D. F. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02879.x · Cited by 84
Deininger, M. H., & Schluesener, H. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00257-4 · Cited by 74
Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome
Kaufmann, W. E., Worley, P. F., Taylor, C. V., Bremer, M. E., & Isakson, P. C. (1997) · Brain and Development · doi:10.1016/s0387-7604(96)00047-2 · Cited by 73
Reder, A. T., Thapar, M., Sapugay, A. M., & Jensen, M. A. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90238-0 · Cited by 68
Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease
Chang, J. W., Coleman, P. D., & O'Banion, M. K. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00110-8 · Cited by 63
Hoozemans, J. J. M., Veerhuis, R., Rozemuller, A. J. M., Arendt, T., & Eikelenboom, P. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.028 · Cited by 61
Fretland, D. J. (1992) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(92)90080-3 · Cited by 51
Dapsone to delay symptoms in Creutzfeldt-Jakob disease
Manuelidis, L., Fritch, W., & Zaitsev, I. V. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79191-1 · Cited by 49
Cyclooxygenases and Central Nervous System Inflammation: Conceptual Neglect of Cyclooxygenase 1
Schwab, J. M., & Schluesener, H. J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.630 · Cited by 49
Graham, S. H., & Hickey, R. W. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.628 · Cited by 45
Inhibitors of Cyclooxygenases produce Amnesia for a Passive Avoidance Task in the Chick
Hölscher, C. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01127.x · Cited by 44
Cyclo-oxygenase inhibitors protect against prion-induced neurotoxicity in vitro
Bate, C., Rutherford, S., Gravenor, M., Reid, S. W. J., & Williams, A. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00021 · Cited by 29
Cyclooxygenase-1 and -2 in Brains of Patients who Died with Sporadic Creutzfeldt-Jakob Disease
Deininger, M. H., Bekure, K., Trautmann, K., Morgalla, M. H., Meyermann, R., & Schluesener, H. J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:1:25 · Cited by 27
Minghetti, L., Hughes, P., & Perry, V. H. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00739-8 · Cited by 10
Self-citationRole for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Zujovic (2000) · doi:10.1002/(sici)1098-1136(20000215)29:4
Cited by
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Luo, Y., Zhao, X., Zhou, J., Yang, J., Zhang, Y., Kuang, W., Peng, J., Chen, L., & Zeng, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00680-8 · Cited by 916
S100B's double life: Intracellular regulator and extracellular signal
Donato, R., Sorci, G., Riuzzi, F., Arcuri, C., Bianchi, R., Brozzi, F., Tubaro, C., & Giambanco, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.009 · Cited by 731
Fernandes, E. S., Passos, G. F., Medeiros, R., da Cunha, F. M., Ferreira, J., Campos, M. M., Pianowski, L. F., & Calixto, J. B. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.059 · Cited by 593
Metadata
- Authors
- Minghetti, L.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09
- Volume
- 63
- Issue
- 9
- Pages
- 901-910
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W2147830608
- Cited by
- 779
- References
- 71
- FWCI
- 17.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.